NCT07619456

Brief Summary

Interest in monitoring intrarenal pressure (IRP) during flexible ureteroscopy (fURS) has grown, especially due to its potential association with improved postoperative efficiency and safety. A prominent technique for managing IRP during fURS is the use of ureteral access sheaths (UAS), which are known to reduce IRP. Suction-equipped access sheaths provide additional benefits by continuously evacuating dust and stone fragments during the procedure, potentially enhancing stone-free rates. However, IRP during suctioning procedures has yet to be thoroughly investigated. The aim of this study is to compare the IRP during fURS using UAS with and without suctioning technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 3, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 26, 2026

Last Update Submit

May 26, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Intrarenal Pressure (IRP) During Flexible Ureteroscopy

    Continuous measurement of intrarenal pressure using the LithoVue Elite ureteroscope system.

    Intraoperative (during procedure)

  • Time spent above Intrarenal Pressure (IRP) threshold during Flexible Ureteroscopy

    Time spent above Intrarenal Pressure (IRP) thresholds of 20, 40, 60, 80, and 100 mmHg using the LithoVue Elite ureteroscope system.

    Intraoperative (during procedure)

Secondary Outcomes (3)

  • Stone-Free Rate (SFR) on Postoperative CT Imaging

    4-8 weeks postoperatively

  • Postoperative Pain Score (VAS)

    In the Post-Anesthesia Care Unit (PACU), prior to discharge on the day of surgery (on average 1.5 hours post operatively)

  • Number of Postoperative Complications

    30 days postoperatively

Study Arms (2)

Suctioning-UAS

EXPERIMENTAL

Placement of the ClearPETRA Flexible and Navigable Suction UAS during flexible ureteroscopy with continuous suction applied during stone treatment.

Device: Suctioning-UAS

Non-suctioning-UAS

ACTIVE COMPARATOR

Placement of the BSC Navigator during flexible ureteroscopy without suction during stone treatment.

Device: Non-suctioning-UAS

Interventions

Participants undergoing flexible ureteroscopy (fURS) will receive a suctioning ureteral access sheath using the ClearPETRA Flexible and Navigable Suction UAS. Continuous intrarenal pressure (IRP) measurements will be recorded throughout the procedure using the LithoVue Elite ureteroscope system.

Suctioning-UAS

Participants undergoing flexible ureteroscopy (fURS) will receive a standard non-suctioning ureteral access sheath using the BSC Navigator device. Continuous intrarenal pressure (IRP) measurements will be recorded throughout the procedure using the LithoVue Elite ureteroscope system.

Non-suctioning-UAS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years and older.
  • Diagnosed with kidney stones and scheduled for fURS.
  • Stone burden \> 1 cm and/or multiple stones will be eligible.
  • Able and willing to provide informed consent.

You may not qualify if:

  • Pregnant persons as determined by pre-operative urine pregnancy test (standard of care at our institution)
  • Untreated UTI
  • Patients with urinary anomalies (e.g., urinary diversion, ureteral reconstruction, horseshoe kidney)
  • Single stone \< 1 cm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai West

New York, New York, 10019, United States

Location

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Officials

  • Mantu Gupta, MD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Surgeon will not be blinded to the UAS type (suctioning vs. non-suctioning) but will be blinded to IRP measurements during the procedure.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 2, 2026

Study Start

April 3, 2025

Primary Completion

October 10, 2025

Study Completion

December 5, 2025

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

To to protect participant privacy

Locations